ロード中...
Highly active RRMS and ocrelizumab after failure of alemtuzumab therapy
BACKGROUND: A high multiple sclerosis activity while on alemtuzumab is rather uncommon compared to moderate-efficacy drugs. The purpose of this case report is to present a case of a 37-year-old female patient with bronchial asthma and no other medical history, whose disease activity required switchi...
保存先:
| 出版年: | BMC Neurol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7240916/ https://ncbi.nlm.nih.gov/pubmed/32438901 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-020-01789-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|